Rang	Name	Position
1	Dr. Stephen Pakola M.D.	Executive VP & Chief Medical Officer
2	Mr. Mitchell Chan M.B.A.	Executive VP & CFO
3	Mr. Craig Malzahn	Executive VP of Product Development & CTO
4	Dr. Olivier Danos Ph.D.	Executive VP & Chief Scientific Officer
5	Dr. Ram Palanki Pharm.D.	Executive VP & Chief Commercial Officer
6	Dr. Jahannaz Dastgir D.O.	Clinical Development Lead

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	9,69%	46,32 Mio. USD
2	Redmile Group, LLC	6,62%	31,63 Mio. USD
3	State Street Corp	4,50%	21,51 Mio. USD
4	JPMorgan Chase & Co	3,35%	16,03 Mio. USD
5	Vanguard Capital Management, LLC	3,19%	15,26 Mio. USD
6	Morgan Stanley - Brokerage Accounts	2,96%	14,14 Mio. USD
7	The Goldman Sachs Group Inc	2,15%	10,29 Mio. USD
8	AQR Capital Management LLC	2,09%	9,98 Mio. USD
9	Vanguard Portfolio Management, LLC	2,05%	9,81 Mio. USD
10	Marshall Wace Asset Management Ltd	1,95%	9,30 Mio. USD
11	Geode Capital Management, LLC	1,88%	8,99 Mio. USD
12	Integral Health Asset Management, LLC	1,21%	5,79 Mio. USD
13	Nuveen, LLC	1,12%	5,36 Mio. USD
14	Dimensional Fund Advisors, Inc.	1,11%	5,30 Mio. USD
15	D. E. Shaw & Co LP	1,08%	5,16 Mio. USD
16	Two Sigma Investments LLC	1,01%	4,85 Mio. USD
17	Citadel Advisors Llc	1,01%	4,84 Mio. USD
18	Stifel Financial Corp	0,85%	4,06 Mio. USD
19	Bank of America Corp	0,79%	3,75 Mio. USD
20	22NW, LP	0,75%	3,57 Mio. USD